APA (7th ed.) Citation

Maccecchini, M. L., Chang, M. Y., Pan, C., John, V., Zetterberg, H., & Greig, N. H. (2012). Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: Target engagement, tolerability and pharmacokinetics in humans. Journal of neurology, neurosurgery and psychiatry, 83(9), 894-902. https://doi.org/10.1136/jnnp-2012-302589

Chicago Style (17th ed.) Citation

Maccecchini, Maria L., Mee Young Chang, Catherine Pan, Varghese John, Henrik Zetterberg, and Nigel H. Greig. "Posiphen as a Candidate Drug to Lower CSF Amyloid Precursor Protein, Amyloid-β Peptide and τ Levels: Target Engagement, Tolerability and Pharmacokinetics in Humans." Journal of Neurology, Neurosurgery and Psychiatry 83, no. 9 (2012): 894-902. https://doi.org/10.1136/jnnp-2012-302589.

MLA (9th ed.) Citation

Maccecchini, Maria L., et al. "Posiphen as a Candidate Drug to Lower CSF Amyloid Precursor Protein, Amyloid-β Peptide and τ Levels: Target Engagement, Tolerability and Pharmacokinetics in Humans." Journal of Neurology, Neurosurgery and Psychiatry, vol. 83, no. 9, 2012, pp. 894-902, https://doi.org/10.1136/jnnp-2012-302589.